Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of Global and mainly European Clinical Pre- and Post-Marketing Safety regulatory requirements

戻る Agenda

TOPIC 5 CONTINUED

Speaker(s)

An Overview of the Risk Management Process & the PRAC. The main components of the RMP

Julie Williams, PHD

MHRA, United Kingdom

Expert Assessor

Joint MHRA/DIA Excellence in Pharmacovigilance

TOPIC 5 CONTINUED

Speaker(s)

An Overview of the Risk Management Process & the PRAC. The main components of the RMP

最新情報や機会を逃さないで